Trial intelligence / Profile preview

Ibuprofen 600 mg ER in dental pain

NCT01266161Phase 3Completed

Sponsor
Pfizer
Start
Nov 2010
Primary completion
Mar 2011
Modality
Small Molecules
Countries
1
01

Overview

A Phase 3 trial of ibuprofen in odontalgia, sponsored by Pfizer. Started Nov 2010; status: completed.

02

Drugs

ibuprofen
03

Conditions

odontalgia

Beyond the preview

Go deeper on NCT01266161.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01266161.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call